8 Stocks You Can Count On During Any Crisis - 2 of 8

 
 

#2 - Dollar General (NYSE:DG)

Another retailer that is built to weather any crisis is Dollar General (NYSE:DG). Dollar General has been on a building binge as it expanded its brick-and-mortar footprint across the nation. The company has more locations than any other retail chain. This means they have a footprint in smaller areas that are not serviced by the larger chains.

 In the last week, I decided to patronize my local Dollar General, not only for the price, but simply because it felt more responsible to travel to a store that was only a few miles away as opposed to the five or so more miles it would have taken to go to my nearest superstore.

That growth may slow down from what the company initially has forecast, but that should not have much effect on the stock. That’s because the company is still well-positioned to thrive through the current pandemic.

The company offers products at low prices, which will turn out to be in high demand as many customers are suddenly finding themselves unemployed. And Dollar General may be able to help out in that regard as well. The company has announced its intention to hire over 50,000 new employees to help meet the expected demand.

After an initial decline in the initial stages of the coronavirus crash, DG stock has turned positive for the year. But with so much uncertainty still surrounding when our national sheltering will occur, Dollar General still appears to have a long runway.

About Dollar General

Dollar General Corporation, a discount retailer, provides various merchandise products in the southern, southwestern, midwestern, and eastern United States. It offers consumable products, including paper and cleaning products, such as paper towels, bath tissues, paper dinnerware, trash and storage bags, disinfectants, and laundry products; packaged food comprising cereals, pasta, canned soups, fruits and vegetables, condiments, spices, sugar, and flour; and perishables that include milk, eggs, bread, refrigerated and frozen food, beer, and wine. Read More 
Current Price
$142.07
Consensus Rating
Hold
Ratings Breakdown
10 Buy Ratings, 14 Hold Ratings, 0 Sell Ratings.
Consensus Price Target
$153.08 (7.7% Upside)

 

Better than Bitcoin? The Biotech Stock with 46,751% Potential (Ad)

4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.

Get the name of the stock here >>>